Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 1
2009 2
2010 6
2011 13
2012 18
2013 17
2014 22
2015 28
2016 21
2017 26
2018 17
2019 23
2020 36
2021 42
2022 29
2023 26
2024 21
2025 26
2026 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

339 results

Results by year

Filters applied: . Clear all
Page 1
Retrospective evaluation of the "neutrophil-lymphocyte ratio" (NLR) in patients affected by locally advanced unresectable stage III NSCLC treated with Durvalumab within the Italian expanded access program (EAP): results of the neutrality trial.
Mattioli C, Olmetto E, Banini M, Garlatti P, Caini S, Riccio MD, Finocchiaro G, Borghetti P, Pilotto S, Metro G, Grossi F, Farina G, Meriggi F, Chella A, Roca E, Zannori C, Delmonte A, Russo A, Macerelli M, Genova C, Cortinovis D, D'Arcangelo M, Del Conte A, Lugini A, Petrelli F, Vasile E, Iannopollo M, Taveggia PA, Quaquarini E, Baldini E, Ponzanelli A, Manzoni M, Cergnul M, Camerini A, Tartarone A, Inno A, Favaretto A, Veccia A, La Torre L, Perna M, Livi L, Bruni A, Scotti V. Mattioli C, et al. Among authors: petrelli f. Cancer Treat Res Commun. 2026 Feb 7;47:101132. doi: 10.1016/j.ctarc.2026.101132. Online ahead of print. Cancer Treat Res Commun. 2026. PMID: 41707549 Free article.
339 results